{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T18:30:59Z","timestamp":1775759459632,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.urolonc.2025.08.026","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T04:58:47Z","timestamp":1758949127000},"page":"693.e1-693.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association of interleukin-6 serum levels with local tumor stage and lymph node metastasis of urothelial carcinoma"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2126-7305","authenticated-orcid":false,"given":"Benedikt","family":"Ebner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annkathrin","family":"Holz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannic","family":"Volz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lennert","family":"Eismann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Hermans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Pyrgidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Kidess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Semmler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah Takayama","family":"Fouladgar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iason","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Chaloupka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Apfelbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Marcon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Weinhold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Ewert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Kazmierczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian G.","family":"Stief","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald B.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.urolonc.2025.08.026_bib0001","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.euo.2022.04.008","article-title":"Contemporary Staging for Muscle-Invasive Bladder Cancer: Accuracy and Limitations","volume":"5","author":"Hensley","year":"2022","journal-title":"European Urology Oncology"},{"issue":"1","key":"10.1016\/j.urolonc.2025.08.026_bib0002","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","article-title":"European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines","volume":"85","author":"Alfred Witjes","year":"2024","journal-title":"Eur Urol"},{"issue":"12","key":"10.1016\/j.urolonc.2025.08.026_bib0003","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1007\/s00261-019-02168-z","article-title":"Preoperative imaging for locoregional staging of bladder cancer","volume":"44","author":"Mirmomen","year":"2019","journal-title":"Abdom Radiol (NY)"},{"issue":"3","key":"10.1016\/j.urolonc.2025.08.026_bib0004","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.eururo.2018.04.029","article-title":"Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System)","volume":"74","author":"Panebianco","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.08.026_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2022.110666","article-title":"VI-RADS in bladder cancer: Overview, pearls and pitfalls","volume":"160","author":"Lai","year":"2023","journal-title":"European Journal of Radiology"},{"key":"10.1016\/j.urolonc.2025.08.026_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.110059","article-title":"Diagnostic benefit of multiparametric MRI over contrast-enhanced CT in patients with bladder cancer: A single-center 1-year experience","volume":"146","author":"Hagen","year":"2022","journal-title":"European Journal of Radiology"},{"issue":"4","key":"10.1016\/j.urolonc.2025.08.026_bib0007","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00345-018-2439-8","article-title":"Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis","volume":"37","author":"Crozier","year":"2019","journal-title":"World Journal of Urology"},{"issue":"1","key":"10.1016\/j.urolonc.2025.08.026_bib0008","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.euf.2022.08.015","article-title":"Radiomics Signature Using Manual Versus Automated Segmentation for Lymph Node Staging of Bladder Cancer","volume":"9","author":"Gresser","year":"2023","journal-title":"European Urology Focus"},{"issue":"10","key":"10.1016\/j.urolonc.2025.08.026_bib0009","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1007\/s00259-022-05761-5","article-title":"Feasibility of [(68)Ga]Ga-FAPI-46 PET\/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma","volume":"49","author":"Unterrainer","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.urolonc.2025.08.026_bib0010","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-024-01823-2","article-title":"Tumor biomarkers for diagnosis, prognosis and targeted therapy","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"3","key":"10.1016\/j.urolonc.2025.08.026_bib0011","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0022-5347(05)65348-7","article-title":"Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer","volume":"167","author":"Andrews","year":"2002","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2025.08.026_bib0012","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00262-021-02953-0","article-title":"Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer","volume":"71","author":"Schuettfort","year":"2022","journal-title":"Cancer Immunol Immunother"},{"issue":"9","key":"10.1016\/j.urolonc.2025.08.026_bib0013","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1007\/s13277-016-5098-7","article-title":"Role of interleukin-6 in cancer progression and therapeutic resistance","volume":"37","author":"Kumari","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.urolonc.2025.08.026_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109130","article-title":"Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach","volume":"111","author":"Aliyu","year":"2022","journal-title":"International Immunopharmacology"},{"issue":"7","key":"10.1016\/j.urolonc.2025.08.026_bib0015","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12032-024-02422-5","article-title":"Interleukin-6 serves as a critical factor in various cancer progression and therapy","volume":"41","author":"AaH","year":"2024","journal-title":"Medical Oncology"},{"issue":"8","key":"10.1016\/j.urolonc.2025.08.026_bib0016","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41568-021-00363-z","article-title":"Interleukins in cancer: from biology to therapy","volume":"21","author":"Briukhovetska","year":"2021","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.urolonc.2025.08.026_bib0017","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cytogfr.2018.04.004","article-title":"IL-6 family cytokines: Key inflammatory mediators as biomarkers and potential therapeutic targets","volume":"41","author":"Unver","year":"2018","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"10.1016\/j.urolonc.2025.08.026_bib0018","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000505099","article-title":"Interleukin-6: A Masterplayer in the Cytokine Network","volume":"98","author":"Uciechowski","year":"2020","journal-title":"Oncology"},{"issue":"11","key":"10.1016\/j.urolonc.2025.08.026_bib0019","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00011-009-0060-4","article-title":"The major inflammatory mediator interleukin-6 and obesity","volume":"58","author":"Eder","year":"2009","journal-title":"Inflamm Res"},{"issue":"3","key":"10.1016\/j.urolonc.2025.08.026_bib0020","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10787-018-0458-0","article-title":"IL-6 signalling pathways and the development of type 2 diabetes","volume":"26","author":"Akbari","year":"2018","journal-title":"Inflammopharmacology"},{"issue":"1","key":"10.1016\/j.urolonc.2025.08.026_bib0021","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-73737-6","article-title":"Clinical importance of cytokine (IL-6, IL-8, and IL-10) and vitamin D levels among patients with Type-1 diabetes","volume":"14","author":"Syed Khaja","year":"2024","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.urolonc.2025.08.026_bib0022","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s00345-022-04017-z","article-title":"Treatment trends for muscle-invasive bladder cancer in Germany from 2006 to 2019","volume":"40","author":"Flegar","year":"2022","journal-title":"World J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2025.08.026_bib0023","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/JU.0000000000001855","article-title":"Pathological Downstaging and Survival Outcomes Associated with Neoadjuvant Chemotherapy for Variant Histology Muscle Invasive Bladder Cancer","volume":"206","author":"Chakiryan","year":"2021","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2025.08.026_bib0024","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2024.2445781","article-title":"Prognostic and clinicopathological value of C-reactive protein in patients with bladder cancer: a meta-analysis","volume":"57","author":"Feng","year":"2025","journal-title":"Annals of Medicine"},{"issue":"12","key":"10.1016\/j.urolonc.2025.08.026_bib0025","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.urolonc.2016.10.006","article-title":"Emerging role of immunotherapy in urothelial carcinoma-Immunobiology\/biomarkers","volume":"34","author":"Sweis","year":"2016","journal-title":"Urol Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2025.08.026_bib0026","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrurol.2017.190","article-title":"Immunotherapy in metastatic urothelial carcinoma: focus on immune checkpoint inhibition","volume":"15","author":"Siefker-Radtke","year":"2018","journal-title":"Nature Reviews Urology"},{"issue":"1","key":"10.1016\/j.urolonc.2025.08.026_bib0027","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mce.2011.05.033","article-title":"Interleukin-6: A multifunctional targetable cytokine in human prostate cancer","volume":"360","author":"Culig","year":"2012","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"6","key":"10.1016\/j.urolonc.2025.08.026_bib0028","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s12094-019-02192-x","article-title":"Prognostic role of interleukin-6 in renal cell carcinoma: a meta-analysis","volume":"22","author":"Wang","year":"2020","journal-title":"Clin Transl Oncol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925003394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925003394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T23:18:59Z","timestamp":1763680739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143925003394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1078143925003394"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.08.026","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of interleukin-6 serum levels with local tumor stage and lymph node metastasis of urothelial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.08.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}